-
Clinical and Experimental Gastroenterology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Organic anion transporting polypeptide 1B3 (OATP1B3) is overexpressed in colorectal tumors and is a predictor of clinical outcome
Original Research
(2536) Views (704) Full article downloads
Authors: Albert Craig Lockhart, Elizabeth Harris, Bonnie J LaFleur, Nipun B Merchant, Mary Kay Washington, et al
Published Date November 2008
Volume 2008:1 Pages 1 - 7
DOI: http://dx.doi.org/10.2147/CEG.S3743
Albert Craig Lockhart1, Elizabeth Harris1, Bonnie J LaFleur1, Nipun B Merchant1, Mary Kay Washington1, Murray B Resnick2, Timothy J Yeatman3, Wooin Lee4
1Vanderbilt University Medical Center, Nashville, TN, USA; 2Brown University Medical Center, Providence, RI, USA; 3Moffitt Cancer Center, Tampa, FL, USA; 4University of Kentucky, Lexington, KY, USA
Background and aims: OATP1B3 is an organic anion transporting polypeptide (OATP) that functions as a multispecific transporter in the normal liver. We examined the expression and clinical significance of OATP1B3 in colon cancers in tissue microarrays.
Methods: Immunohistochemistry was used to assess OATP1B3 protein expression in paraffinized colon tumor tissue microarrays. OATP1B3 immunostaining was evaluated by location and intensity. Relationships between OATP1B3 expression, known prognostic variables and clinical outcomes were examined.
Results: 278 colon tumor samples of all stages were evaluated for OATP1B3 expression. OATP1B3 immunostaining was detectable in the majority (56%) of the tumor samples. Higher OATP1B3 expression was seen in lower stage tumors (p = 0.003) and lower grade (p = 0.004) tumors, but was not predictive of 5-year survival or tumor recurrence as an independent variable. Within individual tumor grades, OATP1B3 expression was associated with improved 5-year survival, but not recurrence in patients with poorly differentiated tumors.
Conclusion: OATP1B3 expression was seen in the majority of colon tumors and may be a marker of lower grade and lower stage tumors and may predict for improved outcome in certain tumors.
Keywords: tissue array analysis, colon neoplasms, organic anion transporters, tumor markers, immunohistochemistry
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Oropharyngeal Crohn’s disease
- Amino acid-responsive Crohn's disease: a case study
- Methylnaltrexone in the treatment of opioid-induced constipation
- Selected luminal mucosal complications of adult celiac disease




